Biotech

All Articles

Analysts go into Avidity's DMD gain, showing subtleties in data

.Avidity Biosciences satisfied real estate investors along with period 1/2 records in Duchenne muscu...

Actinogen's cortisol blocker stops working period 2 depression research

.Actinogen Medical's cortisol blocker has actually missed out on the key endpoint of a phase 2 study...

Bivictrix makes a decision going exclusive only technique to take ADC into facility

.Antibody-drug conjugates (ADCs) have actually gone to the center of a lot of a billion-dollar biobu...

TPG leadings up funds to $580M for assets all over life sciences

.Possession manager TPG, which has assisted biotechs including Sionna Therapies and Santa Ana Bio, h...

Merck stops phase 3 TIGIT test in bronchi cancer cells for futility

.Merck &amp Co.'s TIGIT course has actually gone through another problem. Months after shuttering a ...

After a hard year, Exscientia folds right into Recursion

.After a year defined through pipeline hairstyles, the variation of its own chief executive officer ...

Cullinan, after $25M deal, hands back bispecific to Harbour

.Cullinan Rehab was wowed enough along with Harbour BioMed's bispecific immune activator that it tur...

A better consider Ferocious Biotech's Strong 15

.Within this week's incident of "The Top Pipe," our team're diving into Ferocious Biotech's annual F...

Lilly faces phase 2 breakdown of tau-targeting med

.The confetti is still flying from Eli Lilly's celebration commemorating the commendation of Alzheim...

Biogen CMO Maha Radhakrishnan signs up with Sofinnova-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our roundup of substantial leadership hirings, firings as...